Avid Radiopharmaceuticals

About:

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

Website: http://www.avidrp.com

Top Investors: BioAdvance, Safeguard Scientifics, AllianceBernstein, Pfizer Venture Investments, Alta Partners

Description:

Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.

Total Funding Amount:

$69.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2005-01-01

Contact Email:

carpenter(AT)avidrp.com

Founders:

Daniel M. Skovronsky

Number of Employees:

51-100

Last Funding Date:

2009-05-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai